Specialty Renal Products, Inc.

Specialty Renal Products, Inc. focuses on developing advanced dialysis filtration technologies, ensuring patient safety and treatment efficacy for individuals with kidney failure through innovative filtration solutions and systems. Specialty Renal Products, Inc. is a company dedicated to providing cutting-edge filtration solutions for dialysis treatment.

The company is headquartered in the United States and has undergone significant development since its inception. Daron Evans is the CEO, leading the company's strategy to enhance dialysis care. In September 2018, the company secured USD 3. 000 mn in Series A funding, co-led by Arbor Capital and Wexford Capital, totaling the amount raised to USD 3.

000 mn. Nephros specializes in dialysis filtration products designed to ensure safe and effective dialysis treatment for patients with kidney failure. Their core offerings include ultrafilters that provide a barrier against microbial hazards, such as Legionella, and advanced water filtration systems that meet or exceed AAMI standards for dialysis water quality. Nephros products are utilized in both clinic-based and home dialysis settings, catering to dialysis treatment providers, healthcare teams, and patients.

The company's filtration solutions serve to eliminate waste products, bacteria, and endotoxins from water used in hemodialysis, thereby enhancing patient safety and treatment efficacy. Nephros markets its products primarily in North America, Europe, and select regions in Asia, targeting healthcare facilities, dialysis centers, and home care providers. The revenue generation model for Nephros is structured around the sale of their dialysis filtration products and associated services, with transactions typically occurring through direct sales to healthcare providers and dialysis centers. The company engages in B2B transactions, supplying their filtration systems and maintenance support to clinics and hospitals that require high-quality water for dialysis treatments.

Specific product offerings, such as the FDA-cleared ultrafilters and comprehensive water management solutions, form the backbone of their revenue stream. Pricing plans are structured to accommodate both one-time purchases and long-term support agreements, which may include maintenance and installation services. This structured approach to sales ensures a steady revenue flow while meeting the ongoing needs of their client base in the dialysis healthcare sector. Specialty Renal Products, Inc.

plans to leverage the recent funding from September 2018 to enhance its product line with innovative dialysis filtration solutions aimed at improving patient outcomes. The company is focused on expanding its market reach, particularly in Europe and select regions in Asia, by 2020. The Series A funding of USD 3. 000 mn will support the development of new products and the expansion of their sales operations into these targeted markets.